NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.62% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 5.07% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.97% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.91% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 4.90% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.84% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.76% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.67% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.58% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.51% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 3.79% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.69% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.54% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.21% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.96% |